CHF 4226 pMDI (Carmoterol)

carmoterol · Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHF 4226 pMDI (Carmoterol), covering 2010-08-27 to 2010-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD [Phase 2]